A 3,000-square-foot facility that will treat patients with advanced prostate cancer, neuroendocrine tumors and thyroid cancer
A 'fraction' of the cost of proton therapy systems
A look around the industry at the latest technology entering the market
Using automation to expedite cancer treatment planning
Will create an interoperable, integrated workflow
Insight from Stephanie Kriston, senior director of health policy, market access and reimbursement at Elekta
What payers may overlook when weighing the cost of proton treatment
Surveying the road to financially incentivized algorithm-based healthcare services
Will resume operations in fifth treatment room
Follow-up to FLASH proton trial for bone cancer in extremities
First longitudinal proton therapy study for children with craniopharyngioma
May represent a step toward prioritizing value over volume
The latest in a string of lawsuits pressuring insurers to expand coverage
ASTRO appoints new president-elect
